Compare XENE & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XENE | HWKN |
|---|---|---|
| Founded | 1996 | 1938 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 2.7B |
| IPO Year | 2014 | 1995 |
| Metric | XENE | HWKN |
|---|---|---|
| Price | $36.43 | $130.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 3 |
| Target Price | $72.43 | ★ $174.00 |
| AVG Volume (30 Days) | ★ 2.0M | 107.1K |
| Earning Date | 11-02-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | $311,000.00 | ★ $1,083,696,000.00 |
| Revenue This Year | N/A | $7.95 |
| Revenue Next Year | $2,045.70 | $7.46 |
| P/E Ratio | ★ N/A | $97.95 |
| Revenue Growth | N/A | ★ 11.21 |
| 52 Week Low | $33.38 | $116.05 |
| 52 Week High | $72.66 | $174.12 |
| Indicator | XENE | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 27.70 | 58.81 |
| Support Level | N/A | $130.08 |
| Resistance Level | $43.68 | $137.23 |
| Average True Range (ATR) | 1.18 | 3.28 |
| MACD | 0.55 | 0.26 |
| Stochastic Oscillator | 21.64 | 85.63 |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.